E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/9/2006 in the Prospect News Biotech Daily, Prospect News Convertibles Daily and Prospect News High Yield Daily.

Elan plans redemption of $254 million 6.5% convertibles, some 7¼% notes

By Jennifer Chiou

New York, Nov. 8 - Elan Corp., plc announced plans to use the proceeds from a notes offering to redeem its $254 million of 6.5% convertible guaranteed notes due 2008 and repay some of its $613 million of 7¼% guaranteed senior notes due 2008.

The Dublin, Ireland-based biotechnology company said its wholly owned subsidiaries, Elan Finance plc and Elan Finance Corp., intend to offer $500 million of senior fixed-rate notes due 2013 and senior floating-rate notes due 2013.

The 6.5% convertibles were issued by Elan Capital Corp. Ltd. and the 7¼% notes were issued by Athena Neurosciences Finance, LLC.

Elan added that the net proceeds from the offering are also expected to be used to repay any convertibles not converted into equity of Elan - at a conversion price of $7.42 per share - prior to the redemption date.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.